First Fiduciary Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Sell
73,221
-17,801
-20% -$4.15M 3.51% 7
2026
Q1
$22.2M Buy
91,022
+2,342
+3% +$546K 4.48% 4
2025
Q4
$18.4M Sell
88,680
-3,942
-4% -$780K 3.56% 7
2025
Q3
$17.2M Sell
92,622
-475
-0.5% -$81.4K 3.34% 8
2025
Q2
$14.2M Buy
93,097
+998
+1% +$153K 2.82% 12
2025
Q1
$15.3M Sell
92,099
-3,416
-4% -$534K 3.28% 7
2024
Q4
$13.8M Buy
95,515
+2,701
+3% +$419K 2.81% 11
2024
Q3
$15M Sell
92,814
-323
-0.3% -$51.5K 3.01% 10
2024
Q2
$13.6M Sell
93,137
-774
-0.8% -$115K 2.95% 9
2024
Q1
$14.9M Sell
93,911
-2,357
-2% -$375K 3.08% 7
2023
Q4
$15.1M Buy
96,268
+2,937
+3% +$450K 3.33% 7
2023
Q3
$14.5M Sell
93,331
-1,161
-1% -$192K 3.41% 8
2023
Q2
$15.6M Buy
94,492
+808
+0.9% +$130K 3.4% 7
2023
Q1
$14.5M Sell
93,684
-1,937
-2% -$313K 3.22% 9
2022
Q4
$16.9M Sell
95,621
-2,958
-3% -$511K 3.7% 5
2022
Q3
$16.1M Sell
98,579
-1,415
-1% -$239K 4.04% 4
2022
Q2
$17.8M Sell
99,994
-2,670
-3% -$476K 4.02% 4
2022
Q1
$18.2M Sell
102,664
-1,476
-1% -$251K 3.55% 7
2021
Q4
$17.8M Buy
104,140
+721
+0.7% +$118K 3.16% 10
2021
Q3
$16.7M Sell
103,419
-3,331
-3% -$568K 3.26% 10
2021
Q2
$17.6M Sell
106,750
-2,707
-2% -$448K 3.37% 10
2021
Q1
$18M Sell
109,457
-14,209
-11% -$2.3M 3.43% 11
2020
Q4
$19.5M Sell
123,666
-706
-0.6% -$104K 3.64% 11
2020
Q3
$18.5M Buy
124,372
+560
+0.5% +$82.9K 3.85% 9
2020
Q2
$17.4M Buy
123,812
+698
+0.6% +$102K 3.05% 12
2020
Q1
$16.1M Sell
123,114
-1,690
-1% -$240K 4.28% 8
2019
Q4
$18.2M Buy
124,804
+670
+0.5% +$90.9K 3.39% 11
2019
Q3
$16.1M Buy
124,134
+2,088
+2% +$275K 3.4% 12
2019
Q2
$17M Sell
122,046
-19,932
-14% -$2.76M 3.6% 11
2019
Q1
$19.8M Sell
141,978
-2,479
-2% -$332K 3.67% 10
2018
Q4
$18.6M Buy
144,457
+725
+0.5% +$101K 3.81% 10
2018
Q3
$19.9M Buy
143,732
+3,407
+2% +$453K 3.71% 8
2018
Q2
$17M Buy
140,325
+4,225
+3% +$527K 3.27% 12
2018
Q1
$17.4M Buy
136,100
+492
+0.4% +$66.5K 3.47% 12
2017
Q4
$18.9M Sell
135,608
-4,985
-4% -$694K 3.45% 12
2017
Q3
$18.3M Buy
140,593
+357
+0.3% +$47.3K 3.34% 13
2017
Q2
$18.6M Sell
140,236
-45,377
-24% -$5.79M 3.55% 13
2017
Q1
$23.1M Sell
185,613
-1,207
-0.6% -$144K 4.47% 5
2016
Q4
$21.5M Buy
186,820
+3,289
+2% +$380K 4.12% 4
2016
Q3
$21.7M Buy
183,531
+36,854
+25% +$4.47M 4.57% 2
2016
Q2
$14.3M Sell
146,677
-39,738
-21% -$4.52M 3.2% 15
2016
Q1
$20.2M Sell
186,415
-387
-0.2% -$40.1K 4.42% 2
2015
Q4
$19.2M Buy
186,802
+690
+0.4% +$69.4K 4.34% 3
2015
Q3
$17.4M Buy
186,112
+37,655
+25% +$3.64M 4.18% 4
2015
Q2
$14.5M Buy
148,457
+5,080
+4% +$509K 3.13% 15
2015
Q1
$14.4M Buy
143,377
+3,352
+2% +$341K 3.11% 18
2014
Q4
$14.6M Buy
140,025
+8,155
+6% +$859K 3.06% 17
2014
Q3
$14.1M Sell
131,870
-5,925
-4% -$615K 3.19% 11
2014
Q2
$14.4M Buy
137,795
+80
+0.1% +$8.09K 3.18% 9
2014
Q1
$13.5M Sell
137,715
-1,554
-1% -$144K 3.09% 12
2013
Q4
$12.8M Sell
139,269
-46,740
-25% -$4.31M 2.97% 16
2013
Q3
$16.1M Buy
186,009
+251
+0.1% +$22.5K 4.09% 1
2013
Q2
$15.9M Buy
+185,758
New +$15.8M 4.18% 1

Other funds holding JNJ

First Fiduciary Investment Counsel's JNJ Position: Q2 2026 in Review

First Fiduciary Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 20% in Q2 2026, selling an estimated $4.15M and leaving 73,221 shares worth $18.6M. The position accounts for 3.51% of the portfolio, ranked #7.

First Fiduciary Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.1M in Q1 2017. 3,371 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • First Fiduciary Investment Counsel held 73,221 shares of Johnson & Johnson worth $18.6M as of Q2 2026.
  • First Fiduciary Investment Counsel sold 17,801 Johnson & Johnson shares in Q2 2026, an estimated $4.15M.
  • Johnson & Johnson made up 3.51% of First Fiduciary Investment Counsel's portfolio in Q2 2026, its #7 holding.
  • First Fiduciary Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • First Fiduciary Investment Counsel's Johnson & Johnson position peaked at $23.1M in Q1 2017.
  • 3,371 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on First Fiduciary Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.